These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32269966)

  • 1. The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models.
    Blanquart C; Jaurand MC; Jean D
    Front Oncol; 2020; 10():388. PubMed ID: 32269966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.
    Meiller C; Montagne F; Hirsch TZ; Caruso S; de Wolf J; Bayard Q; Assié JB; Meunier L; Blum Y; Quetel L; Gibault L; Pintilie E; Badoual C; Humez S; Galateau-Sallé F; Copin MC; Letouzé E; Scherpereel A; Zucman-Rossi J; Le Pimpec-Barthes F; Jaurand MC; Jean D
    Genome Med; 2021 Jul; 13(1):113. PubMed ID: 34261524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
    Gao Y; Kruithof-de Julio M; Peng RW; Dorn P
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and characterization of patient derived xenograft model of malignant peritoneal mesothelioma in nude mice].
    Yang ZR; Lin YL; Zhang J; Ma R; Li Z; Jiang X; Zhao HY; Du XM; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):162-167. PubMed ID: 32074730
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical Models of Malignant Mesothelioma.
    Testa JR; Berns A
    Front Oncol; 2020; 10():101. PubMed ID: 32117751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived xenografts as compatible models for precision oncology.
    Cho SY
    Lab Anim Res; 2020; 36():14. PubMed ID: 32461927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms.
    Cersosimo F; Barbarino M; Lonardi S; Vermi W; Giordano A; Bellan C; Giurisato E
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma - A Review.
    Johnson BW; Takahashi K; Cheng YY
    Front Oncol; 2021; 11():748444. PubMed ID: 34900693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma.
    Tranchant R; Quetel L; Montagne F; De Wolf J; Meiller C; De Koning L; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
    Lung Cancer; 2018 Dec; 126():15-24. PubMed ID: 30527180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
    Pyo DH; Hong HK; Lee WY; Cho YB
    Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.
    Pignochino Y; Dell'Aglio C; Inghilleri S; Zorzetto M; Basiricò M; Capozzi F; Canta M; Piloni D; Cemmi F; Sangiolo D; Gammaitoni L; Soster M; Marchiò S; Pozzi E; Morbini P; Luisetti M; Aglietta M; Grignani G; Stella GM
    BMC Cancer; 2015 May; 15():374. PubMed ID: 25952930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis.
    Martarelli D; Catalano A; Procopio A; Orecchia S; Libener R; Santoni G
    BMC Cancer; 2006 May; 6():130. PubMed ID: 16704740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed.
    Cortes-Dericks L; Carboni GL; Schmid RA; Karoubi G
    Int J Oncol; 2010 Aug; 37(2):437-44. PubMed ID: 20596671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine.
    Kalla J; Pfneissl J; Mair T; Tran L; Egger G
    Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38806997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the biology of malignant pleural mesothelioma.
    Zucali PA; Ceresoli GL; De Vincenzo F; Simonelli M; Lorenzi E; Gianoncelli L; Santoro A
    Cancer Treat Rev; 2011 Nov; 37(7):543-58. PubMed ID: 21288646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
    Colella G; Fazioli F; Gallo M; De Chiara A; Apice G; Ruosi C; Cimmino A; de Nigris F
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29466296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Tumor Immunology and Immunotherapy in Mice.
    Buqué A; Galluzzi L
    Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and Prospects of Patient-Derived Xenografts for Cancer Research.
    Jin J; Yoshimura K; Sewastjanow-Silva M; Song S; Ajani JA
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
    Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W
    J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.